Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Apr;68(4):741-8.
doi: 10.1111/j.1476-5381.1980.tb10867.x.

The interaction of human haemoglobin with allosteric effectors as a model for drug-receptor interactions

The interaction of human haemoglobin with allosteric effectors as a model for drug-receptor interactions

P J Goodford et al. Br J Pharmacol. 1980 Apr.

Abstract

1 The release of bound oxygen from oxyhaemoglobin by allosteric effectors is considered as a model for those drug-receptor interactions where the primary response to agonist binding is the release of a second messenger species. 2 A theory of haemoglobin oxygenation, based on the two-state model of Monod, Wyman & Changeux (1965) is used to predict the relationship between 'pharmacological' response and dose of agonist. This relationship is the same as that derived from classical pharmacological occupancy theory. 3 The potency of an agonist is a weighted average of its affinities for the two conformational states of the receptor. 4 The efficacy of an agonist depends not only upon its binding to one of the two conformational states, but also on its ability to alter the functional properties of that state by lowering the affinity of the state for the second messenger. 5 2,3-Diphosphoglycerate and adenosine triphosphate are approximately equipotent and of similar efficacy, but inositol hexaphosphate is about 500 times more potent and has a higher efficacy.

PubMed Disclaimer

References

    1. Biochemistry. 1976 AUG 24;15(17):3890-901 - PubMed
    1. Proc Natl Acad Sci U S A. 1968 Feb;59(2):526-32 - PubMed
    1. Br J Pharmacol. 1976 Jun;57(2):201-9 - PubMed
    1. Nat New Biol. 1971 Dec 8;234(49):174-6 - PubMed
    1. J Physiol. 1978 Oct;283:397-407 - PubMed

LinkOut - more resources